These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1587414)

  • 21. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
    Sponsel WE; Paris G; Trigo Y; Pena M
    Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced intraocular pressure after cataract surgery in patients with narrow angles and chronic angle-closure glaucoma.
    Brown RH; Zhong L; Whitman AL; Lynch MG; Kilgo PD; Hovis KL
    J Cataract Refract Surg; 2014 Oct; 40(10):1610-4. PubMed ID: 25134991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
    Gagliuso DJ; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
    Vysniauskiene I; Shaarawy T; Flammer J; Haefliger IO
    Br J Ophthalmol; 2005 Jul; 89(7):809-11. PubMed ID: 15965155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term home monitoring of intraocular pressure in pediatric glaucoma.
    Bitner DP; Freedman SF
    J AAPOS; 2016 Dec; 20(6):515-518. PubMed ID: 27702611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy and longevity of nonpenetrating glaucoma surgery with and without a new, nonabsorbable hydrophilic implant.
    Dahan E; Ravinet E; Ben-Simon GJ; Mermoud A
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):457-63. PubMed ID: 14620748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of latanoprost additive therapy on uncontrolled glaucoma.
    Bayer A; Tas A; Sobaci G; Henderer JD
    Ophthalmologica; 2002; 216(6):443-8. PubMed ID: 12566890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posture-induced intraocular pressure changes in eyes with open-angle glaucoma, primary angle closure with or without glaucoma medications, and control eyes.
    Sawada A; Yamamoto T
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7631-5. PubMed ID: 23099489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma.
    Sabri K; Levin AV
    J AAPOS; 2006 Oct; 10(5):464-8. PubMed ID: 17070484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low first postoperative day intraocular pressure as a positive prognostic indicator in deep sclerectomy.
    Shaarawy T; Flammer J; Smits G; Mermoud A
    Br J Ophthalmol; 2004 May; 88(5):658-61. PubMed ID: 15090419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Five years retrospective study of latanoprost glaucoma treatment].
    Závorková M; Susický P
    Cesk Slov Oftalmol; 2007 Jul; 63(4):292-8. PubMed ID: 17682609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of intranasal steroids to intraocular pressure.
    Bergmann J; Witmer MT; Slonim CB
    Curr Allergy Asthma Rep; 2009 Jul; 9(4):311-5. PubMed ID: 19656479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular pressure reduction after phacoemulsification with intraocular lens implantation in glaucomatous and nonglaucomatous eyes: evaluation of a causal relationship between the natural lens and open-angle glaucoma.
    Poley BJ; Lindstrom RL; Samuelson TW; Schulze R
    J Cataract Refract Surg; 2009 Nov; 35(11):1946-55. PubMed ID: 19878828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma.
    Skaat A; Jasien JV; Ritch R
    J Glaucoma; 2016 Sep; 25(9):e807-14. PubMed ID: 27552517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys.
    Wang RF; Gagliuso DJ; Podos SM
    J Glaucoma; 2008; 17(1):73-8. PubMed ID: 18303390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study.
    Miller Ellis E; Berlin MS; Ward CL; Sharpe JA; Jamil A; Harris A
    Br J Ophthalmol; 2017 Jun; 101(6):796-800. PubMed ID: 27649982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to control measurement variation in estimating the mean intraocular pressure reducing effect at a specific point in time.
    Hedman K; Taube A
    Contemp Clin Trials; 2005 Jun; 26(3):402-15. PubMed ID: 15911474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.